from-tgc
Read about ProPublica’s lawsuit against the Food and Drug Administration (FDA) over drug safety transparency for generics made in overseas factories with records of violations.
Explore how crypto scam networks quickly rebuilt after a Telegram crackdown on Chinese black markets halted, raising questions about platform responsibility.
Read how executive orders, political pressures, and shifting norms are converging, forcing compliance leaders to navigate risk with clarity.
The Mental Health Parity and Addiction Equity Act is currently paused, but core compliance obligations remain in effect. What does this mean for your team?
The Committee of Sponsoring Organizations of the Treadway Commission’s (COSO) Corporate Governance Framework redefines strategy as a core compliance responsibility, placing ethics and risk at the heart of value creation.
New guidance from the Food and Drug Administration (FDA) shows how Remote Regulatory Assessments (RRA) may reshape compliance under the Drug Supply Chain Security Act (DSCSA).
Digital collaboration agents are moving beyond chatbot prompts to act independently. Understand why legal departments should prepare for a new kind of digital partner.
Understand the difference between Japan’s new AI bill, which charts a course for innovation, and the regulation-focused EU AI Act passed earlier this year.
Explore why Trump Mobile fits neatly into the wireless Industry’s business structure, even if it does pose a classic conflict of interest.
Learn why a phishing campaign by an APT group using advanced malware and zero-day attack techniques can exploit a critical Chrome vulnerability.
Daily Updates
Sign up for our free daily newsletter for the latest news and business legal developments.
